Immunogene therapy (Briana Bio-Tech)

N/A

Report date: 2022/03/14 18:05:54

Base Information

Drug NameImmunogene therapy (Briana Bio-Tech)
Drug Alias NameB7-2 gene therapy - Briana Bio-Tech
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionImmunostimulantsCluster of differentiation 86 modulators
TargetsCluster of differentiation 86
Therapy Area/IndicationsMelanomaGlioma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Alberta
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsMelanomaGlioma

Other Information

ATC CodeN/A
Related LinksN/A